Downloads: 1 | Views: 112 | Weekly Hits: ⮙1 | Monthly Hits: ⮙1
Comparative Studies | Anaesthesiology | India | Volume 12 Issue 2, February 2023
A Prospective Study Comparing Post Cesarean Analgesia of Transversusabdominis Plane Block Using 0.25 % Ropivacaine, 0.25 % Ropivacaine with Dexmedetomidine and 0.25 % Ropivacaine with Clonidine
Dr. Swetha Vahana Reddy Maddur | Dr. Joga Aparna [4] | Dr. G. Vijaya Lakshmi [5] | Dr. Madala Krishnaveni [2]
Abstract: Introduction: Postoperative pain control after cesarean delivery (CD) is an important issue for patients and health care providers. The plan for analgesia after CD must facilitate bonding between the mother and her neonate and allow safe breastfeeding. Methods: Patients admitted to GSL medical college undergoing elective and emergency (where no maternal and fetal compromise exists) lower segment cesarean section were included in the study after ethical committee clearance and informed written consent. Results: The total dose of Inj. Ketorolac used in 24hours in Group II was 39.6?14.3mg; in Group III was 81.6?18.4mg; and in Group I was 94.8?16.6mg. There was a statistically significant difference between the three groups (p<0.0001). Group II had the lowest analgesic consumption in 24 hours and this was statistically significant when compared to Group III (p<0.0001) and Group I (p<0.0001). Conclusion: To conclude TAP block is a safe and effective way of relieving postoperative pain in LSCS patients and addition of dexmedetomidine to ropivacaine significantly enhances its effect in terms of block quality and duration of analgesia. Also addition of dexmedetomidine to ropivacaine in TAP block reduces the overall analgesic consumption in a multimodal approach to pain when compared to plain ropivacaine or clonidine addition to TAP block.
Keywords: Postoperative pain, analgesia, the mother and her neonate, lower segment cesarean section, Inj. Ketorolac, TAP block, dexmedetomidine, ropivacaine, duration, clonidine, ethical committee, written consent
Edition: Volume 12 Issue 2, February 2023,
Pages: 1507 - 1509